Tech Company Financing Transactions

Alios BioPharma Funding Round

Alios BioPharma closed a $41 million Series B venture capital round on 4/8/2014. Investors included private investors, Novartis Venture Fund and Novo Ventures.

Transaction Overview

Company Name
Alios BioPharma
Announced On
4/8/2014
Transaction Type
Venture Equity
Amount
$41,000,000
Round
Series B
Investors

private investors (Lead Investor)

Novartis Venture Fund (Campbell Murray)

Novo Ventures (Jack Nielsen)

Roche Venture Fund (Carole Nuechterlein)

SR One Capital Management (Jens Eckstein)

Proceeds Purpose
Proceeds from this financing will be used primarily to support continued clinical development of Alios' respiratory portfolio, including AL-8176, an anti-RSV nucleoside analog now in Phase 2 clinical development, and multiple late-stage preclinical development programs targeting Influenza and Rhinovirus.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
260 East Grand Ave. 2nd Floor
South San Francisco, CA 94080
USA
Phone
(650) 635-5500
Website
www.aliosbiopharma.com
Email Address
[email protected]
Overview
Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferona).
Profile
Alios BioPharma LinkedIn Company Profile
Social Media
Alios BioPharma Company Twitter Account
Company News
Alios BioPharma News
Facebook
Alios BioPharma on Facebook
YouTube
Alios BioPharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lawrence Blatt
  Lawrence Blatt LinkedIn Profile  Lawrence Blatt Twitter Account  Lawrence Blatt News  Lawrence Blatt on Facebook
Chief Scientific Officer
Leonid Beigelman
  Leonid Beigelman LinkedIn Profile  Leonid Beigelman Twitter Account  Leonid Beigelman News  Leonid Beigelman on Facebook
Founder
John Donovan
  John Donovan LinkedIn Profile  John Donovan Twitter Account  John Donovan News  John Donovan on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/8/2014: Trinity Pharma venture capital transaction
Next: 4/8/2014: Updater venture capital transaction

 

Share this article

 

About Database of VC Transactions

Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.